SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-24-003432
Filing Date
2024-05-09
Accepted
2024-05-09 17:29:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 CORVUS PHARMACEUTICALS, INC. p24-1750sc13g.htm SC 13G 67505
2 JOINT FILING AGREEMENT p24-1750exhibit99.htm EX-99.1 6319
  Complete submission text file 0000902664-24-003432.txt   75388
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Subject) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89443 | Film No.: 24932071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)